A BBC investigation into cheap overseas eyelid surgery has documented a pattern travel insurers should recognise immediately: patients flying home the same day as their procedure, against explicit medical advice, with complications surfacing mid-journey or shortly after landing, then requiring NHS emergency treatment.
Faceland, a Dutch company operating clinics in the Netherlands, Germany and Switzerland, says it has carried out more than 2,950 blepharoplasty ("bleph") procedures on UK patients since October 2024. One patient, Nikita Morgan, told the BBC she flew home the same day as her surgery despite advice against it, describing bleeding through her stitches mid-flight: "It was like I was crying blood." She has since said she regrets the decision and warns others against it.
The pattern extends beyond travel timing. UK surgeons surveyed by the BBC, 63 members of the British Oculoplastic Surgery Society, said the most common complication they see following overseas bleph procedures is patients unable to close their eyes properly, alongside scarring and wound reopening. Consultant oculoplastic surgeon Colin Vize said aftercare "should be available to a patient 24/7," noting that a doctor based hundreds of miles away cannot realistically provide that kind of immediate care.
For UK travel insurers, the specific fact pattern matters: complications are not occurring as a result of an unrelated illness during travel, but as a foreseeable consequence of a planned elective procedure the patient knew about before departure, in some cases against direct medical advice not to fly. That raises concrete underwriting questions around disclosure of planned overseas surgery, and whether complications following advice not to travel could sit inside or outside standard exclusion wording.
At least one patient, referred to as Laura, is pursuing legal action against Faceland after her wounds reopened following treatment; the company's own complaints process offered her £150, which she rejected. Faceland says it offers "safe and quality" treatments and that fewer than 1% of procedures have led to a complaint, though it confirmed this figure excludes patients who required revision surgery.
Given the scale involved, nearly 3,000 UK patients from a single provider in under two years, brokers writing travel cover for clients considering medical tourism, or advising clients who mention cosmetic procedures abroad, have a concrete reason to revisit how clearly current policy wording addresses planned elective surgery and post-operative travel against medical advice.
